657 related articles for article (PubMed ID: 26440929)
1. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
2. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
3. Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.
South SA; Vance H; Farrell C; DiCioccio RA; Fahey C; Piver MS; Rodabaugh KJ
Cancer; 2009 Jan; 115(2):324-33. PubMed ID: 19117025
[TBL] [Abstract][Full Text] [Related]
4. PMS2 involvement in patients suspected of Lynch syndrome.
Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
[TBL] [Abstract][Full Text] [Related]
5. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
6. BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.
Ferrone CR; Levine DA; Tang LH; Allen PJ; Jarnagin W; Brennan MF; Offit K; Robson ME
J Clin Oncol; 2009 Jan; 27(3):433-8. PubMed ID: 19064968
[TBL] [Abstract][Full Text] [Related]
7. Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.
Case AS; Zighelboim I; Mutch DG; Babb SA; Schmidt AP; Whelan AJ; Thibodeau SN; Goodfellow PJ
Gynecol Oncol; 2008 Feb; 108(2):438-44. PubMed ID: 18022218
[TBL] [Abstract][Full Text] [Related]
8. Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome.
Rahner N; Friedrichs N; Wehner M; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
Acta Oncol; 2007; 46(6):763-9. PubMed ID: 17653898
[TBL] [Abstract][Full Text] [Related]
9. Novel MLH1 duplication identified in Colombian families with Lynch syndrome.
Alonso-Espinaco V; Giráldez MD; Trujillo C; van der Klift H; Muñoz J; Balaguer F; Ocaña T; Madrigal I; Jones AM; Echeverry MM; Velez A; Tomlinson I; Milà M; Wijnen J; Carvajal-Carmona L; Castells A; Castellví-Bel S
Genet Med; 2011 Feb; 13(2):155-60. PubMed ID: 21233718
[TBL] [Abstract][Full Text] [Related]
10. Pediatric duodenal cancer and biallelic mismatch repair gene mutations.
Roy S; Raskin L; Raymond VM; Thibodeau SN; Mody RJ; Gruber SB
Pediatr Blood Cancer; 2009 Jul; 53(1):116-20. PubMed ID: 19283792
[TBL] [Abstract][Full Text] [Related]
11. Hereditary cancer syndromes.
Fostira F; Thodi G; Konstantopoulou I; Sandaltzopoulos R; Yannoukakos D
J BUON; 2007 Sep; 12 Suppl 1():S13-22. PubMed ID: 17935271
[TBL] [Abstract][Full Text] [Related]
12. Risk of pancreatic cancer in families with Lynch syndrome.
Kastrinos F; Mukherjee B; Tayob N; Wang F; Sparr J; Raymond VM; Bandipalliam P; Stoffel EM; Gruber SB; Syngal S
JAMA; 2009 Oct; 302(16):1790-5. PubMed ID: 19861671
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
14. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
Kastrinos F; Stoffel EM; Balmaña J; Steyerberg EW; Mercado R; Syngal S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2044-51. PubMed ID: 18708397
[TBL] [Abstract][Full Text] [Related]
15. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
Hall MJ
J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and management of Lynch syndrome.
Boland CR
Clin Adv Hematol Oncol; 2007 Nov; 5(11):851,873. PubMed ID: 18185481
[No Abstract] [Full Text] [Related]
17. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).
Rahner N; Steinke V; Schlegelberger B; Olschwang S; Eisinger F; Hutter P
Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20104243
[No Abstract] [Full Text] [Related]
19. Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome.
Kratz CP; Holter S; Etzler J; Lauten M; Pollett A; Niemeyer CM; Gallinger S; Wimmer K
J Med Genet; 2009 Jun; 46(6):418-20. PubMed ID: 19293170
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of unclassified variants in mismatch repair genes.
Pastrello C; Pin E; Marroni F; Bedin C; Fornasarig M; Tibiletti MG; Oliani C; Ponz de Leon M; Urso ED; Della Puppa L; Agostini M; Viel A
Genet Med; 2011 Feb; 13(2):115-24. PubMed ID: 21239990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
